Multi-Symptom Allergy 325 mg/1
Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl · TABLET, COATED · Walgreen Company
Multi-Symptom Allergy is a prescription tablet, coated containing acetaminophen, chlorpheniramine maleate, phenylephrine hcl at 325 mg/1, taken oral. Manufactured by Walgreen Company.
Key Facts
- Brand Name
- Multi-Symptom Allergy
- Generic Name
- Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl
- NDC Code (Product)
0363-0559- Manufacturer
- Walgreen Company
- Strength
- 325 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- HUMAN OTC DRUG
- Application #
- M012
- Drug Class
- Adrenergic alpha1-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]
- Marketing Start
- 03/27/2008
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Uses temporarily relieves these symptoms of hay fever or other upper respiratory allergies: runny nose and sneezing nasal congestion minor aches and pains headache sinus congestion and pressure temporarily relieves these additional symptoms of hay fever: itchy, watery eyes itching of the nose or throat helps clear nasal passages helps decongest sinus openings and passages
Dosage & Administration
Directions do not take more than directed adults and children 12 years and over take 2 gelcaps every 4 hours do not take more than 10 gelcaps in 24 hours children under 12 years: ask a doctor
Warnings
Warnings Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take more than 4,000 mg of acetaminophen in 24 hours with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include: skin reddening blisters rash If a skin reaction occurs, stop use and seek medical help right away. Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. if you have ever had an allergic reaction to this product or any of its ingredients Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis high blood pressure heart disease diabetes liver disease difficulty in urina…
Frequently Asked Questions
What is Multi-Symptom Allergy used for?
Multi-Symptom Allergy contains Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is Multi-Symptom Allergy a controlled substance?
Multi-Symptom Allergy is not classified as a controlled substance by the DEA.
What is the generic name for Multi-Symptom Allergy?
The generic name for Multi-Symptom Allergy is Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl. There are 11 other brand versions of Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl.
What is the NDC code for Multi-Symptom Allergy 325 mg/1?
The NDC (National Drug Code) for Multi-Symptom Allergy 325 mg/1 is 0363-0559, listed by Walgreen Company.
Other Acetaminophen, Brands
See all →- Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl500 mg/169729-322
- SINUS PAIN AND CONGESTION59779-779
- FLONASE Headache and Allergy Relief325 mg/10135-0578
- Pentrexcilina Daytime500 mg/169729-223
- COLDTAC ULTRA500 mg/169729-133
- RESFRIOL D500 mg/169729-323
- Antigrip Extra Strength325 mg/155758-500
- Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl500 mg/169729-122
- Allergy Multi-Symptom325 mg/150844-455
- Cold Medicine325 mg/163654-275
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)